English

BioStock Investor Pitch: Brain+

Report this content

Brain+ is a health tech company focused on treatment and management of dementia. Centred around the Cognitive Stimulation Therapy method, the company’s approach has the potential to revolutionize dementia care. Brain+ is now raising capital to pursue commercialisation in the UK.

Read the presentation at biostock.se:

BioStock Investor Pitch: Brain+ - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock Investor Pitch: Brain+
Tweet this